# A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

> **NCT06049017** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 252 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** JNJ-77242113
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06049017
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-09
- **Primary completion:** 2024-09-26
- **Final completion:** 2026-01-05
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049017, "A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06049017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*